Clinical Trial Update: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating adjuvant therapy with immune checkpoint blocking antibodies versus observation in completely re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: Prof. Dr. med. Dirk Schadendorf | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: COMPLETED